ENTEROCOCCI TEAM CASE STUDY 2 Team Table 6: Emerita Arias Ofili Okolonwamu Romelene Juban Microbioloy Bio 16 Dr. Janet Fulks 12 October 2006
Diagnosis Joseph Lincoln is a 62 year old coronary-by- pass patient that has been in ICU since his surgery. This week he began to exhibit symptoms of pneumonia. A sputum specimen was sent for culture and sensitivity. The lab reported a Gram stain with GPC and numerous WBCs. The culture displayed organisms identified as Enterococci. The sensitivity for the organism reveals a resistance to Vancomycin.
Pictures (1) Vancomycin- Resistant Enterococci (VRE) (2) (3)
Characteristics GP cocci Environmental conditions Facultative anaerobe Tolerate sodium azide & concentrated bile salts Strains are homofermentative Glucose fermentation Inhibit in humans & other animals Species: E. faecium & E. faecalis Two types: Intrinsic and Acquired (4)
Meaning of the Resistance Displayed Prophylactic practice Opportunistic Microorganisms Over-prescription of Vancomycin Treatment of MRSA=VRE VanA, VanB
Bacteria DNA Exchange Intrinsic Resistance vs. Acquired Resistance Conjugation
Suggested treatment for patient Isolates bacteria VRE treatment driven bacterial antibiotic resistance VRE resistant to gentamicin VRE high-level penicillin resistant VRE intrinsic pen G/AMP resistance VRE: Ampicillin, Vancomycin, & Aminoglycoside resistance Current treatments by microbiology report
Patient Prognosis Prognosis based on patient level of resistant & other factors Recovering rate is 50/50 chance
Special Precautions Isolated room Universal precaution IV ABT Therapy Series of microbiology lab test Therapeutic level test (Peak & Trough)
References Picture # 1: Picture # 2: l l Picture # 3: l l Picture # 4: w3.ouhsc.edu/enterococcus/news.asp Bauman, Robert. Microbiology Alternate Edition with Disease by Body System. Copyright 2006 by Pearson Education Inc., San Francisco, CA. The Stanford Guide to Antimicrobial Therapy 2006